MedPath

Three-arm, cluster-randomized controlled study to assess the effects of FASTER and SCOTT trainings for adults with high-functioning autism spectrum disorder (ASD)

Phase 3
Recruiting
Conditions
F84.1
F84.5
F84.0
Atypical autism
Childhood autism
Asperger syndrome
Registration Number
DRKS00017817
Lead Sponsor
Klinik für Psychiatrie und PsychotherapieUniversitätsklinikum FreiburgMedizinische Fakultät
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
360
Inclusion Criteria

(+) Diagnosis of autism or Asperger syndrome, high-functioning (ICD-10: F84.0, F84.5 or F84.1 if DSM criterion A, social communication and social interaction is true)
(+) Age between 18 and 65
(+) IQ at least 80
(+) Relevant psychosocial impairment [global assessment of function (GAF) score = 60]
(+) Fluent German language of patient and parent / spouse / other close person to enable filling out of questionnaires and understanding instructions
(+) Ability of subject to understand character and individual consequences of clinical trial
(+) Written informed consent
(+) No severe reading or writing disability
(+) none, or stable psychopharmacotherapy
(+) Existence of one person for external assessment (SRS-A, parent/ spouse/ other)

Exclusion Criteria

(-) Psychiatric comorbidities: acute (florid) psychosis, acute (florid) schizophrenia, acute bipolar disorder, acute severe depression, acute suicidality
(-) substance abuse/ substance dependecies within the last 12 months
(-) Present or past gambling disorder
(-) Not corrected severe vision or hearing impairment
(-) A history of severe group disturbing behaviour
(-) Any neurological disorder or medical condition interfering with group therapy
(-) Group-based social skills training or other structured psychotherapy for the core symptoms of ASD (current or in the last 6 months prior tot he study, structured psychotherapy for comorbid disorders are allowed)
(-) inpatient treatment at T0

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SRS-A external assessment, difference four months after randomization, after four month therapy with 16 sessions
Secondary Outcome Measures
NameTimeMethod
(1a) Difference of change of STS-A scores between FASTER and SCOTT&EVA. <br>(1b) Difference of change of SRS-A self-report total sum score <br>(1c) Differences of change of SRS-A external assessment and self-report for the five subscores <br>(1d) Differences of change of SRS-A modified for the total score and the five subscores (self-report and external assessment)<br><br>(2) Changes in social cognition [MET]<br><br>General psychiatric well-being <br>[(3) depression: BDI-II, (4) global functioning: GAF, (5) social anxiety and social skills deficit: SASKO]<br><br>(6) Quality of life [WHOQoL-BREF], <br><br>(7) self-esteem [MSWS] and <br><br>(8) life satisfaction [FLZ] <br><br>(9) Partnership questionnaire, if appropriate
© Copyright 2025. All Rights Reserved by MedPath